Smart science to improve lives™

Mexico

Formed as a joint venture company in 1977, Croda Mexico is today wholly owned by Croda. We are located in Ciudad de Mexico (CDMX), the country’s main economic, financial, business and cultural centre. In addition to sales, marketing and customer service, our offices also have an applications laboratory supporting customers across Latin America. 

With strong working relationships across the Croda Group the team benefits from many personal and professional development opportunities and enjoys donating working time to take part in Croda 1% Club activities. 
office in mexico

Croda Mexico

Av. Paseo de la Reforma 296, Piso 17, Oficina B
Colonia Juárez, Del. Cuauhtémoc, Mexico City
Mexico D.F., C.P 06600
Tel: +52 55 36405710
 

Iberchem Mexico S.A. de C.V.

Alfredo Nobel No. 3, 3 y 4
Col. Fraccionamiento Industrial Los Reyes
Estado de México
54073 Tlalnepantla
Mexico
Tel: +52 55 5565 5450

 
Our Innovation Centre at global headquarters Cowick Hall

Contact us

Whether you’re a customer, potential partner, job seeker or investor, please use our contact us form for your enquiry.

Croda Formulator at work in labs

Where we operate

Every day our global team, across 37 countries, work together to inspire our customers.

Further reading

Croda will sponsor the IFSCC Congress

19 May 2022: Croda will support the 2022 IFSCC Congress with Platinum Sponsorship

Read more

Exclusive license for Croda to commercialise SSI’s CAF® vaccine adjuvants

Croda International Plc, announces today that it has entered a strategic collaboration with Statens Serum Institut (“SSI”), the leading Danish Governmental life-science research institute.

Read more

Record financial performance strategy executed with agility

Results for the year ended 31 December 2021.

Read more
Laboratory work

UK Government to support expansion of Croda's lipid systems manufacturing facility

This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.

Read more